Trial Profile

A multicenter, double-blind, placebo-controlled, clinical trial to evaluate the efficacy and safety of two concentrations (100 DPP/ml and 300 DPP/ml) of a mixture of depigmented polymerized allergenic extracts of D. pteronyssinus and D. farinae , in patients suffering from allergic rhinoconjunctivitis with or without controlled asthma

Status: Not yet recruiting

Phase of Trial: Phase III

Latest Information Update: 17 Nov 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs House dust mite allergy immunotherapy Laboratorios LETI (Primary) ; Beclometasone/formoterol; Budesonide; Desloratadine; Fluticasone furoate; Levocabastine; Montelukast; Salbutamol sulfate; Terbutaline
Indications Allergic rhinoconjunctivitis
Focus Registrational; Therapeutic Use
Sponsors LETI Pharma GmbH

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com